QS Investors’s Antares Pharma, Inc. ATRS Stock Holding History

QS Investors’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$525K	Hold	120,200	–	–	0.01%	718
2021 Q1	$495K	Hold	120,200	–	–	0.01%	804
2020 Q4	$480K	Hold	120,200	–	–	0.01%	804
2020 Q3	$325K	Sell	120,200 -514,200	-81%	-$1.42M	﹤0.01%	893
2020 Q2	$1.75M	Buy	634,400 +600	+0.1%	+$1.67K	0.02%	544
2020 Q1	$1.5M	Buy	633,800 +2,100	+0.3%	+$7.14K	0.02%	534
2019 Q4	$2.69M	Buy	631,700 +366,700	+138%	+$1.5M	0.03%	488
2019 Q3	$887K	Hold	265,000	–	–	0.01%	807
2019 Q2	$872K	Hold	265,000	–	–	0.01%	836
2019 Q1	$803K	Buy	+265,000	New	+$859K	0.01%	870

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

QS Investors's ATRS Position: Q2 2021 in Review

QS Investors held its Antares Pharma, Inc. (ATRS) position steady in Q2 2021 at 120,200 shares worth $525K. The position accounts for 0.01% of the portfolio, ranked #718.

QS Investors first reported a position in ATRS in Q1 2019 and has held it in 10 quarters since. The position peaked at $2.69M in Q4 2019. 175 funds tracked by Wall St. Rank hold ATRS as of Q2 2021.

QS Investors held 120,200 shares of Antares Pharma, Inc. worth $525K as of Q2 2021.
QS Investors left its Antares Pharma, Inc. share count unchanged in Q2 2021.
Antares Pharma, Inc. made up 0.01% of QS Investors's portfolio in Q2 2021, its #718 holding.
QS Investors first reported a position in Antares Pharma, Inc. in Q1 2019 and has held it in 10 quarters since.
QS Investors's Antares Pharma, Inc. position peaked at $2.69M in Q4 2019.
175 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.